1. Home
  2. BDSX vs GMM Comparison

BDSX vs GMM Comparison

Compare BDSX & GMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • GMM
  • Stock Information
  • Founded
  • BDSX 2005
  • GMM 2017
  • Country
  • BDSX United States
  • GMM China
  • Employees
  • BDSX N/A
  • GMM N/A
  • Industry
  • BDSX Precision Instruments
  • GMM
  • Sector
  • BDSX Health Care
  • GMM
  • Exchange
  • BDSX Nasdaq
  • GMM Nasdaq
  • Market Cap
  • BDSX 53.2M
  • GMM 61.9M
  • IPO Year
  • BDSX 2020
  • GMM 2023
  • Fundamental
  • Price
  • BDSX $0.41
  • GMM $2.40
  • Analyst Decision
  • BDSX Strong Buy
  • GMM
  • Analyst Count
  • BDSX 5
  • GMM 0
  • Target Price
  • BDSX $1.75
  • GMM N/A
  • AVG Volume (30 Days)
  • BDSX 1.4M
  • GMM 23.6K
  • Earning Date
  • BDSX 08-07-2025
  • GMM 08-18-2025
  • Dividend Yield
  • BDSX N/A
  • GMM N/A
  • EPS Growth
  • BDSX N/A
  • GMM N/A
  • EPS
  • BDSX N/A
  • GMM 1.78
  • Revenue
  • BDSX $76,556,000.00
  • GMM $48,171,048.00
  • Revenue This Year
  • BDSX $17.29
  • GMM N/A
  • Revenue Next Year
  • BDSX $29.33
  • GMM N/A
  • P/E Ratio
  • BDSX N/A
  • GMM $1.32
  • Revenue Growth
  • BDSX 25.70
  • GMM 41.74
  • 52 Week Low
  • BDSX $0.17
  • GMM $1.69
  • 52 Week High
  • BDSX $2.04
  • GMM $15.60
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 53.27
  • GMM 41.99
  • Support Level
  • BDSX $0.37
  • GMM $2.22
  • Resistance Level
  • BDSX $0.43
  • GMM $2.42
  • Average True Range (ATR)
  • BDSX 0.04
  • GMM 0.19
  • MACD
  • BDSX -0.00
  • GMM -0.03
  • Stochastic Oscillator
  • BDSX 48.25
  • GMM 30.91

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About GMM Global Mofy Metaverse Limited

Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.

Share on Social Networks: